Arginyl-Glutamine (TFA)

Arginyl-Glutamine TFA is a dipeptide that can decrease VEGF levels and inhibit retinal neovascularization in a mouse model of oxygen-induced retinopathy[1].

Product Specifications

Product Name Alternative

H-Arg-Gln-OH (TFA)

UNSPSC

12352209

Target

VEGFR

Related Pathways

Protein Tyrosine Kinase/RTK

Field of Research

Cardiovascular Disease

Purity

99.22

Smiles

N=C(N)NCCC[C@H](N)C(N[C@H](C(O)=O)CCC(N)=O)=O.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F

Molecular Formula

C17H25F9N6O10

Molecular Weight

644.40

References & Citations

[1]Neu J, et al. The dipeptide Arg-Gln inhibits retinal neovascularization in the mouse model of oxygen-induced retinopathy. Invest Ophthalmol Vis Sci. 2006 Jul;47 (7) :3151-5.